C07D 513/08
Bridged systems
C07D513/08 (Bridged systems) appears on 149 US grants and 160 published applications in this corpus.
Search patents in C07D- Granted patents
- 149
- Published applications
- 160
- Assignees
- 93
- Inventors
- 589
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 4 |
| 2003 | 3 | 8 |
| 2004 | 0 | 3 |
| 2005 | 7 | 5 |
| 2006 | 4 | 5 |
| 2007 | 4 | 6 |
| 2008 | 4 | 1 |
| 2009 | 2 | 8 |
| 2010 | 3 | 6 |
| 2011 | 2 | 4 |
| 2012 | 2 | 5 |
| 2013 | 4 | 4 |
| 2014 | 6 | 4 |
| 2015 | 5 | 8 |
| 2016 | 7 | 9 |
| 2017 | 9 | 7 |
| 2018 | 6 | 8 |
| 2019 | 5 | 9 |
| 2020 | 10 | 12 |
| 2021 | 11 | 11 |
| 2022 | 5 | 5 |
| 2023 | 10 | 12 |
| 2024 | 6 | 6 |
| 2025 | 8 | 5 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Synthesis of vinyl cyclobutyl intermediates12 May 2026US 12,623,993 B2Amgen Inc.
- Compound as PPAR agonist and application thereof10 Feb 2026US 12,545,653 B2USA Elixiria Biotech Inc.
- Synthesis of sulfonamide intermediates14 Oct 2025US 12,441,681 B2Amgen Inc.
- Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates14 Oct 2025US 12,441,741 B2Amgen Inc.
- Processes and intermediates for preparing MCL1 inhibitors9 Sep 2025US 12,410,146 B2Gilead Sciences, Inc.
- Lipid monomers for therapeutic delivery of rna17 Sep 2026US 2026/0274883 A1Janssen Biotech, Inc.
- Protein folding agent, compound, protein folding method, pharmaceutical composition, and agent for suppressing cytotoxicity by transition metal3 Sep 2026US 2026/0258077 A1National University Corporation Tokyo University of Agriculture and Technology
- Synthesis of vinyl cyclobutyl intermediates27 Aug 2026US 2026/0250233 A1Amgen Inc.
- Processes and intermediates for preparing mcl1 inhibitors26 Feb 2026US 2026/0055068 A1Gilead Sciences, Inc.
- Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases8 Jan 2026US 2026/0008784 A1
Most cited
By later US patents
- Macrocyclic pyrimidines, their production and use as pharmaceutical agents62US 7,312,225 B2Bayer Schering Pharma Aktiengesellschaft · 2007
- Immunoregulation53US 4,886,796 AThe Australian National University · 1989
- Aryl fused azapolycyclic compounds52US 6,410,550 B1Pfizer Inc. · 2002
- Recombinant methods and materials for producing epothilones C and D48US 6,303,342 B1Kason Biosciences, Inc. · 2001
- Myxococcus host cells for the production of epothilones38US 6,410,301 B1Kosan Biosciences, Inc. · 2002